{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4798"}, "official-title": {"#tail": "\n\t", "#text": "To authorize the Secretary of Health and Human Services to award grants for Alzheimer\u2019s disease\n\t\t\t research."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140602", "#text": "June 2, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "sponsor": {"#tail": " introduced the following bill; which was referred to the ", "#text": "Mr. Israel", "@name-id": "I000057"}, "committee-name": {"#tail": "\n      ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "HDF8B503AE23549A7B57F6BE43AE23AE8", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "United States-Israel Alzheimer\u2019s Disease Cooperation Act", "@value": "United States-Israel Alzheimer\u2019s Disease Cooperation Act", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H3CE6B625F4054A52A1386E47E6EBCAE3"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " finds the following:", "@entity-type": "federal-body", "#text": "Congress", "@entity-id": "0001"}, "#text": "The ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n      ", "#text": "Findings"}, "paragraph": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "It is in the highest national interests of the United States to further research into Alzheimer\u2019s\n\t\t\t disease."}, "enum": {"#tail": "\n        ", "#text": "(1)"}, "@id": "H63AF6C70A77E41E0A50F759AE8CF3A50", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "The State of Israel is a steadfast ally of the United States."}, "enum": {"#tail": "\n        ", "#text": "(2)"}, "@id": "HD64F519C85984CCE9945562EAA547B88", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "The special relationship between the United States and Israel is manifested in a variety of\n\t\t\t cooperative scientific research and development programs, such as\u2014"}, "enum": {"#tail": "\n        ", "#text": "(3)"}, "#text": "\n        ", "@id": "H3BEA90707C574F27A2521249E4186792", "subparagraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "the United States-Israel Binational Science Foundation;"}, "enum": {"#tail": "\n          ", "#text": "(A)"}, "@id": "HF76B8EC19F4048FA80B21F6272EC3FD7", "#text": "\n          "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "#text": "the United States-Israel Binational Industrial Research and Development Foundation; and"}, "enum": {"#tail": "\n          ", "#text": "(B)"}, "@id": "H0F8F41C9877848B0BFC4938AF19888D5", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "the United States-Israel Energy Cooperation Act."}, "enum": {"#tail": "\n          ", "#text": "(C)"}, "@id": "H62E5BDC92FB5415A92E8F9E866C57A59", "#text": "\n          "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Those programs have made possible many scientific, technological, and commercial breakthroughs in\n\t\t\t fields including the life sciences, medicine, bioengineering, agriculture,\n\t\t\t biotechnology, communications, and energy development."}, "enum": {"#tail": "\n        ", "#text": "(4)"}, "@id": "HB9F47859F5F2466AA15028596B9D6D66", "#text": "\n        "}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "Israeli scientists are at the forefront of research and development in the field of Alzheimer\u2019s\n\t\t\t disease."}, "enum": {"#tail": "\n        ", "#text": "(5)"}, "@id": "HCEBD456C584745B48080ADD662973491", "#text": "\n        "}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "Enhanced cooperation between the United States and Israel for the purpose of research in\n\t\t\t Alzheimer\u2019s disease would be in the national interests of both countries."}, "enum": {"#tail": "\n        ", "#text": "(6)"}, "@id": "HAF9B2675E2394CB39245979E7C299FA3", "#text": "\n        "}], "#text": "\n      ", "@id": "HD655D74B754842BE8CBD6F95424BA964"}, {"@section-type": "subsequent-section", "#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n\t\t\t", "#text": "Grants for Alzheimer\u2019s disease research"}, "subsection": [{"#tail": "\n      ", "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Grant program"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (in this section referred to as the ", "@entity-type": "federal-body", "@value": "", "@entity-id": "7500", "#text": "Secretary of Health and Human Services", "@parent-entity-id": ""}, "quote": {"#tail": ") shall establish a program of awarding grants to support research on the development and\n\t\t\t commercialization of applicable tools, treatments, and cures for\n\t\t\t Alzheimer's disease and other dementias.", "#text": "Secretary"}, "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Establishment"}, "#text": "\n          ", "@id": "H17DDA2F7EC3F4465B5ECC0B10C537262"}, {"#tail": "\n        ", "@id": "HD86977E07A654D0AB602E208F4CDBB62", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Eligible projects"}, "text": {"#tail": "\n\t\t\t\t\t", "#text": "To be eligible for funding under this section, a project shall\u2014"}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "; and", "@entity-type": "act", "#text": "paragraph (1)", "@value": "United States-Israel Alzheimer\u2019s Disease Cooperation Act/s:3/ss:a/p:1", "@proposed": "true"}, "#text": "be designed to further research described in "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H142F8B95894D40C19E3A3F25FCE191EA", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "be a joint venture between\u2014"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "clause": [{"#tail": "\n            ", "subclause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "a for-profit business entity, academic institution, National Laboratory (as defined in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": "), or nonprofit entity in\n\t\t\t the United States; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 2 of\n\t\t\t the Energy Policy Act of 2005", "@value": "Energy Policy Act of 2005/s:2"}, "@entity-type": "law-citation", "#text": "\n                    ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                  ", "@entity-type": "uscode", "#text": "42 U.S.C. 15801", "@value": "usc/42/15801"}, "@parsable-cite": "usc/42/15801", "#text": "\n                    ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n                ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                ", "@id": "HF8E0BE5379F64BB7A99332D22B63F41E", "@commented": "no"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "a for-profit business entity, academic institution, or nonprofit entity in Israel; or"}, "enum": {"#tail": "\n                ", "#text": "(II)"}, "#text": "\n                ", "@id": "HAD213D18A29C43DE80C5016282FEBEB3"}], "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(i)"}, "@id": "H615A06B0A89B4635A6C6D6C40E271F14", "#text": "\n              "}, {"#tail": "\n          ", "subclause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the Federal Government; and"}, "enum": {"#tail": "\n                ", "#text": "(I)"}, "@display-inline": "yes-display-inline", "#text": "\n                ", "@id": "HB30D5A12372D47629ED75B0EBB811AE4", "@commented": "no"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "the Government of Israel."}, "enum": {"#tail": "\n                ", "#text": "(II)"}, "#text": "\n                ", "@id": "H6F8458C78EB64C0188D52DCA421B94DD"}], "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(ii)"}, "@id": "H1D3EDDC990C349FCBD2F2C55CF5E433F", "#text": "\n              "}], "#text": "\n            ", "@id": "HF5BDA2A4B9A0464887F0CB97431B9543"}]}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " an application in\n\t\t\t accordance with procedures established by the ", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, {"#tail": " in consultation\n\t\t\t with the advisory board established under ", "@entity-type": "federal-body", "#text": "Secretary,", "@entity-id": "7500"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (4)", "@value": "United States-Israel Alzheimer\u2019s Disease Cooperation Act/s:3/ss:a/p:1", "@proposed": "true"}], "#text": "To seek a grant under this section, an applicant shall submit to the "}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "header": {"#tail": "\n          ", "#text": "Applications"}, "#text": "\n          ", "@id": "H1BE029B296E74ADEA0E92B393BFAA91D"}, {"#tail": "\n        ", "subparagraph": [{"#tail": "\n          ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "to monitor the method by which grants are awarded under this section; and"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "H99A51878DAB54C4B9B376C5E0A69383A", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " periodic performance reviews of actions taken to carry out this\n\t\t\t section.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "to provide to the "}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "HD620BEC735EF480BB97A3ED4D0EADB5D", "#text": "\n              "}], "enum": {"#tail": "\n            ", "#text": "(A)"}, "header": {"#tail": "\n            ", "#text": "Establishment"}, "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall establish an advisory board\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "The "}, "#text": "\n            ", "@id": "H7E414001B63748DBAD121B80D42738F6"}, {"#tail": "\n        ", "clause": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "1 shall be a representative of the Federal Government;"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "H4E183AA5135945B7A44267EC5FF59AB7", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "1 shall be selected from a list of nominees provided by the United States-Israel Binational Science\n\t\t\t Foundation; and"}, "enum": {"#tail": "\n              ", "#text": "(ii)"}, "@id": "H5FCFEC764AFF4C7DBD86DD9CE8C9BDDB", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "1 shall be selected from a list of nominees provided by the United States-Israel Binational\n\t\t\t Industrial Research and Development Foundation."}, "enum": {"#tail": "\n              ", "#text": "(iii)"}, "@id": "H42ED7D50A17146B28EC0C8182C29FB30", "#text": "\n              "}], "enum": {"#tail": "\n            ", "#text": "(B)"}, "header": {"#tail": "\n            ", "#text": "Composition"}, "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be composed of 3 members, to be\n\t\t\t appointed by the ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "United States-Israel Alzheimer\u2019s Disease Cooperation Act/s:3/ss:a/p:4/sp:A", "@proposed": "true"}, {"#tail": ", of whom\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "The advisory board established under "}, "#text": "\n            ", "@id": "HC32D6B5C0CAA4E349A3B45C95B371AC0"}], "enum": {"#tail": "\n          ", "#text": "(4)"}, "header": {"#tail": "\n\t\t\t\t\t", "#text": "Advisory board"}, "#text": "\n          ", "@id": "H792D0E92D3734037BDE0B9223D011443"}, {"#tail": "\n        ", "@id": "H6A772522A9474C3FB30FF20F18A4EA5F", "enum": {"#tail": "\n          ", "#text": "(5)"}, "header": {"#tail": "\n          ", "#text": "Contributed funds"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "uscode", "#text": "\n              ", "external-xref": {"#tail": " of title 31, United States Code", "@parsable-cite": "usc/31/3302", "#text": "section 3302", "@legal-doc": "usc"}, "@value": "usc/31/3302"}, {"#tail": " may accept, retain, and\n\t\t\t use funds contributed by any person, government entity, or organization\n\t\t\t for purposes of carrying out this section\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "Notwithstanding "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "without further appropriation; and"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HFE5A474A5DD64D09BCF51D65185B18DC", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "without fiscal year limitation."}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H4ED8B5234606483BAB17BAD5CFCE5F50", "#text": "\n            "}]}, {"#tail": "\n        ", "@id": "H2EEB1A62F6F3452FAFF2209B21A97E8D", "enum": {"#tail": "\n          ", "#text": "(6)"}, "header": {"#tail": "\n          ", "#text": "Report"}, "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " a\n\t\t\t report that contains\u2014", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}, "#text": "Not later than 180 days after the date of completion of a project for which a grant is provided\n\t\t\t under this section, the grant recipient shall submit to the "}, "#text": "\n          ", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "a description of the method by which the recipient used the grant funds; and"}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H26383A097F1C4A2B9701DB7626B1DF7F", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "an evaluation of the level of success of each project funded by the grant."}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H0277F91850C84199B07CC0AB70F9AD17", "#text": "\n            "}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "Grants shall be awarded under this section only for projects that are considered to be unclassified\n\t\t\t by both the United States and Israel."}, "enum": {"#tail": "\n          ", "#text": "(7)"}, "header": {"#tail": "\n          ", "#text": "Classification"}, "#text": "\n          ", "@id": "HEC32F634FDB4481D82378D0DE98C1885"}], "#text": "\n        ", "@id": "HDDCD06463E9D434EB350E3DCCA906E99"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t", "#text": "The grant program and the advisory committee established under this section terminate on the date\n\t\t\t that is 7 years after the date of enactment of this Act."}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Termination"}, "#text": "\n        ", "@id": "HE8F8EE18F0EC4478BF0DDF62E73327FE"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (a)(5)", "@value": "United States-Israel Alzheimer\u2019s Disease Cooperation Act/s:3/ss:a/p:5", "@proposed": "true"}, "{http://namespaces.cato.org/catoxml}property": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " ", "@entity-type": "act", "#text": "this section", "@value": "United States-Israel Alzheimer\u2019s Disease Cooperation Act/s:3", "@proposed": "true"}, "#text": "to carry out ", "@name": "purpose"}, "#tail": "\n        ", "@entity-type": "auth-auth-approp", "{http://namespaces.cato.org/catoxml}funds-and-year": {"#tail": ". Any amounts appropriated pursuant to this\n\t\t\t subsection shall be in addition to amounts accepted, retained, and used\n\t\t\t pursuant to ", "#text": "$3,000,000 for the period of\n\t\t\t fiscal years 2015 through 2021", "@amount": "3000000", "@year": "2015..2021"}, "#text": "There is authorized to be appropriated "}}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Authorization of appropriations"}, "#text": "\n        ", "@id": "HF9AF1B03A133409DA66E38A4EC371472"}], "#text": "\n      ", "@id": "HA9980B8FF27542D8BAE44E3611C98623"}], "#text": "\n\t\t", "@id": "HDE9BD10BA4BA48AD91390E2BBA8FA0A8"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-06-02"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4798 IH: United States-Israel Alzheimer\u2019s Disease Cooperation Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}